Nocturnal home hemodialysis improves baroreflex effectiveness index of end-stage renal disease patients

Journal of Hypertension

Volumn 26, Issue 9, 2008, Pages 1795-1800

  Chan, Christopher T ^a,b   Shen, Xiou Seeger ^a   Picton, Peter ^a   Floras, John ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b NONE   (Canada)

Author keywords

Arterial compliance; Baroreflex effectiveness index; Baroreflex sensitivity; Daily dialysis; Nocturnal home hemodialysis

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTERY COMPLIANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DRUG WITHDRAWAL; FEMALE; HEART STROKE VOLUME; HOME DIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; MALE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TREATMENT OUTCOME; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; CIRCADIAN RHYTHM; CLINICAL TRIAL; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RENOVASCULAR HYPERTENSION; RISK FACTOR;

ADULT; BAROREFLEX; BLOOD PRESSURE; CIRCADIAN RHYTHM; FEMALE; HEMODIALYSIS, HOME; HUMANS; HYPERTENSION, RENAL; KIDNEY FAILURE, CHRONIC; MALE; RISK FACTORS; STROKE VOLUME; TREATMENT OUTCOME;

EID: 58149269400     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328308b7c8     Document Type: Article

References (38)

1. Floras JS, Hassan MO, Jones JV, Osikowska BA, Sever PS, Sleight P. Consequences of impaired arterial baroreflexes in essential hypertension: effects on pressor responses, plasma noradrenaline and blood pressure variability. J Hypertens 1988; 6:525-535.
2. Parlow J, Viale JP, Annat G, Hughson R, Quintin L. Spontaneous cardiac baroreflex in humans. Comparison with drug-induced responses. Hypertension 1995; 25:1058-1068.
3. Di Rienzo M, Parati G, Castiglioni P, Tordi R, Mancia G, Pedotti A. Baroreflex effectiveness index: an additional measure of baroreflex control of heart rate in daily life. Am J Physiol Regul Integr Comp Physiol 2001; 280:R744-R751.
4. Johansson M, Gao SA, Friberg P, Annerstedt M, Carlstrom J, Ivarsson T, et al. Baroreflex effectiveness index and baroreflex sensitivity predict all- cause mortality and sudden death in hypertensive patients with chronic renal failure. J Hypertens 2007; 25:163-168.
5. Lazarus JM, Hampers CL, Lowrie EG, Merrill JP. Baroreceptor activity in normotensive and hypertensive uremic patients. Circulation 1973; 47:1015-1021.
6. Pickering TG, Gribbin B, Oliver DO. Baroreflex sensitivity in patients on long-term haemodialysis. Clin Sci 1972; 43:645-657.
7. Chan CT, Jain V, Picton P, Pierratos A, Floras JS. Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease. Kidney Int 2005; 68:338-344.
8. Foley RN. Clinical epidemiologyofcardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial 2003; 16:111-117.
9. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. KidneyInt 2002; 61:2235-2239.
10. Butler GC, Senn BL, Floras JS. Influence of atrial natriuretic factor on spontaneous baroreflex sensitivity for heart rate in humans. Hypertension 1995; 25:1167-1171.
11. Pickering TG, Davies J. Estimation of the conduction time of the baroreceptor-cardiac reflex in man. Cardiovasc Res 1973; 7:213-219.
12. Johansson M, Gao SA, Friberg P, Annerstedt M, Bergstrom G, Carlstrom J, etal. Reduced baroreflex effectiveness index in hypertensive patients with chronic renal failure. Am J Hypertens 2005; 18:995-1000; discussion 1016.
13. Floras JS, Hassan MO, Jones JV, Osikowska BA, Sever PS, Sleight P. Factors influencing blood pressure and heart rate variability in hypertensive humans. Hypertension 1988; 11:273-281.
14. Naughton MT, Liu PP, Bernard DC, Goldstein RS, BradleyTD. Treatmentof congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med 1995; 151:92-97.
15. Rahman MA, Hara K, Floras JS. Influence of prior exercise on stroke volume to pulse pressure ratio in young subjects with hypertension or dilated cardiomyopathy. Can J Physiol Pharmacol 1997; 75:1232-1240.
16. Daugirdas JT, Greene T, Depner TA, Gotch FA, Star RA. Relationship between apparent (single-pool) and true (double-pool) urea distribution volume. KidneyInt 1999; 56:1928-1933.
17. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007; 49:S12-S154.
18. Sleight P, Floras JS, Hassan MO, Jones JV, Osikowska BA, Sever P, Turner KL. Baroreflex control of blood pressure and plasma noradrenaline during exercise in essential hypertension. Clin Sci (Lond) 1979; 57 (Suppl 5):169s-171s.
19. Chern CM, Hsu HY, Hu HH, Chen YY, Hsu LC, Chao AC. Effects of atenolol and losartan on baroreflex sensitivity and heart rate variability in uncomplicated essential hypertension. J Cardiovasc Pharmacol 2006; 47:169-174.
20. Melenovsky V, Simek J, Sperl M, Malik J, Wichterle D. Relation between actual heart rate and autonomic effects of beta blockade in healthy men. Am JCardiol 2005; 95:999-1002.
21. Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, etal. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 1999; 340:1321 -1328.
22. Floras JS, Jones JV, Hassan MO, Sleight P. Effects of acute and chronic beta-adrenoceptor blockade on baroreflex sensitivity in humans. J Auton Nerv Syst 1988; 25:87-94.
23. Reyes del Paso GA, Hernandez JA, Gonzalez MI. Differential evaluation of the baroreceptor cardiac reflex effectiveness as a function of sequence length. Int J Psychophysiol 2006; 59:91 -96.
24. Kaji D, Thomas K. Na+-K+ pump in chronic renal failure. Am J Physiol 1987; 252:F785-F793.
25. Chapleau MW, Hajduczok G, Abboud FM. Peripheral and central mechanisms of baroreflex resetting. Clin Exp Pharmacol Physiol Suppl 1989; 15:31-43.
26. Pirisino R, Ghelardini C, De Siena G, Malmberg P, Galeotti N, Cioni L, et al. Methylamine: a new endogenous modulator of neuron firing? Med Sci Monit 2005; 11:RA257-RA261.
27. Floras JS. Reviewer Critique for the American Journal of Hypertension article: 'Reduced baroreflex effectiveness index in hypertensive patients with chronic renal failure' by Johansson et al.. Am J Hypertens 2005; 18:1016.
28. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351:478-484.
29. Osterziel KJ, Dietz R. Improvement of vagal tone by ACE inhibition: a mechanism of cardioprotection in patients with mild-to-moderate heart failure. J Cardiovasc Pharmacol 1996; 27 (Suppl 2):S25-S30.
30. Herzog CA. Sudden cardiac death and acute myocardial infarction in dialysis patients: perspectives of a cardiologist. Semin Nephrol 2005; 25:363-366.
31. Conway J, Boon N, Floras J, Vann Jones J, Sleight P. Impaired control of heart rate leads to increased blood pressure variability. J Hypertens Suppl 1984; 2:S395-S396.
32. Chapleau MW, Cunningham JT, Sullivan MJ, Wachtel RE, Abboud FM. Structural versus functional modulation of the arterial baroreflex. Hypertension 1995; 26:341 -347.
33. Meyer TW, HostetterTH. Uremia. N Engl J Med 2007; 357:1316-1325.
34. Ewing DJ, Winney R. Autonomic function in patients with chronic renal failure on intermittent haemodialysis. Nephron 1975; 15:424-429.
35. Hering D, Zdrojewski Z, Krol E, Kara T, Kucharska W, Somers VK, et al. Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure. J Hypertens 2007; 25:157-161.
36. Chan CT, Harvey PJ, Picton P, Pierratos A, Miller JA, Floras JS. Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension 2003; 42:925-931.
37. Koike MK, Moreira ED, da Silva GJ, Consolim-Colombo FM, Ida F, Irigoyen MC, Krieger EM. Resetting of aortic baroreceptors in response to hypotension does not alter gain sensitivity. Clin Exp Pharmacol Physiol 2006; 33:679-684.
38. Tank J, Diedrich A, Szczech E, Luft FC, Jordan J. Alpha-2 adrenergic transmission and human baroreflex regulation. Hypertension 2004; 43:1035-1041.